pharmaceutical advertising

Pharmaceutical Advertising – It Really Works!

At a time when the drug issue billions of dollars on advertising directly to consumers, research published in the British Medical Journal (BMJ) found that such ads may not be sufficient to return.

The scale direct consumers is enormous, for example, in 2005, the pharmaceutical industry has more than 4 billion U.S. dollars directly to the consumer (DTC) advertising. Howeve

r, the result of the survey conducted by Harvard Medical School raises serious questions about its effectiveness.

"There was no shred of influence against drug addiction for arthritis and allergies”, says Harvard Medical School professor Stephen Soumerai and one of the authors of the study. “Oops if you believe that the advertising was very simple for the medical industry is wrong”.

They argued that research in three and advertising of medicines Etanercept (for rheumatoid arthritis (RA), mometasone furoate (anti-allergic drugs) and Tegaserod are used to treat IBS. Durable, a good five years of study, compared to prescribe French-speaking Canadians designs, 95% of them do not see on television in the United States, the prescribing patterns of Canadians living in the region dominant English, who watch television in the United States.

Although this means that pharmaceutical companies do not have direct advertising to consumers? Perhaps it depends on what is advertised, because when it comes to arthritis and allergy medicines, consumers have many options. And if there are so many competitors trying to beat each other and then there is a strong chance that you will not be lost in the noise.

However, experts believe that direct-to-consumer (DTC) advertising is not priced, as well as to new, innovative therapies.

There are also humorous ads and make side effects. In the meantime, the ground has changed the public narrative of the main causes of adverse reactions by convincing message to lose steam.

Google Search

Newest Articles

Newest News